Published in J Hypertens on May 01, 2002
Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord (2012) 0.88
Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol (2012) 0.86
The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents. Int J Clin Pract (2010) 0.84
A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol (2013) 0.80
Non-steroidal anti-inflammatory drugs and antihypertensive drug therapy. J Hypertens (2002) 0.77
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab (2003) 1.61
Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res (2007) 1.61
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria. Am J Hypertens (2007) 1.56
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens (2005) 1.56
Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension. Hypertens Res (2010) 1.54
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens (2005) 1.49
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation (2009) 1.49
Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension (2003) 1.48
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension (2003) 1.43
Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev (2012) 1.42
Heart rate variability in childhood obesity. Clin Auton Res (2001) 1.41
Early stratification of patients with chest pain and suspected acute coronary syndrome in the Emergency Department. Minerva Med (2010) 1.41
Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension. Hypertens Res (2010) 1.40
Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension (2008) 1.39
Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. J Hypertens (2008) 1.39
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens (2007) 1.36
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol (2003) 1.33
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab (2006) 1.29
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients. Intern Med (2008) 1.19
Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol (2004) 1.17
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16
Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs (2002) 1.11
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. Intern Med (2008) 1.08
Evaluation of blood pressure/height ratio as an index to simplify diagnostic criteria of hypertension in Caucasian adolescents. J Hum Hypertens (2011) 1.08
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol (2006) 1.05
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (2006) 1.02
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens (2008) 1.02
Serum angiotensin converting enzyme (ACE) in silicosis. Eur J Respir Dis (1984) 0.98
Endothelium, aging, and hypertension. Curr Hypertens Rep (2006) 0.97
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. Arthritis Rheum (2007) 0.97
Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens (2007) 0.96
Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging (2004) 0.96
Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients. Am J Hypertens (2002) 0.96
Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab (2006) 0.95
Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur J Endocrinol (2002) 0.95
Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients. Ann N Y Acad Sci (2006) 0.94
Obesity and autonomic function in adolescence. Clin Exp Hypertens (2001) 0.93
alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes. Hypertension (1999) 0.91
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation. Am J Hypertens (2008) 0.90
Relationship between birth weight and blood pressure in adolescence. Prev Med (1999) 0.89
Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab (1998) 0.89
Assessing resting heart rate in adolescents: determinants and correlates. J Hum Hypertens (2002) 0.89
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system. J Hypertens (2011) 0.89
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation. J Cardiovasc Pharmacol Ther (2011) 0.89
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension (2007) 0.88
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther (2004) 0.88
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis. Eur J Gastroenterol Hepatol (2012) 0.88
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab (2006) 0.88
New intrarenal echo-Doppler velocimetric indices for the diagnosis of renal artery stenosis. Kidney Int (2006) 0.88
Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep (2002) 0.87
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol (2002) 0.87
Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens (2004) 0.87
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res (2005) 0.87
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. Mol Cell Endocrinol (2010) 0.87
Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study. Clin Ther (2007) 0.87
Device-guided slow breathing as a non-pharmacological approach to antihypertensive treatment: efficacy, problems and perspectives. J Hypertens (2007) 0.87
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol (2006) 0.86
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. Clin Cardiol (2012) 0.86
Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens (2002) 0.86
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. J Hum Hypertens (2004) 0.86
Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria. Am J Hypertens (2007) 0.85
Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. Int J Cardiol (1992) 0.85
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol (2004) 0.85
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. Eur J Clin Pharmacol (2006) 0.85
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest. Hypertension (2005) 0.85
Antihypertensive drugs and fibrinolytic function. Am J Hypertens (2006) 0.85
Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. J Cardiovasc Pharmacol (2008) 0.85
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. Am J Hypertens (2005) 0.84
Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients. Expert Opin Pharmacother (2011) 0.84
Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res (2005) 0.84
Vasoactive hormones induce nitric oxide synthase mRNA expression and nitric oxide production in human endothelial cells and monocytes. Am J Hypertens (1999) 0.84
Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens (2003) 0.84
A drug safety evaluation of valsartan. Expert Opin Drug Saf (2010) 0.84
Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy. Blood Press Suppl (2003) 0.83
Carotid vascular remodeling in patients with pheochromocytoma. J Clin Endocrinol Metab (2006) 0.83
Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol (2002) 0.83
Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients. J Hum Hypertens (2009) 0.82
Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension (2006) 0.82
Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study. Expert Opin Pharmacother (2011) 0.81
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. J Hypertens (2007) 0.81
Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause. J Nutr Biochem (2012) 0.81
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol (2005) 0.81
Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab (1998) 0.81
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy. Expert Opin Pharmacother (2012) 0.81
Baroreflex control of heart rate is impaired in pre-eclampsia. J Hum Hypertens (1999) 0.81
[Obesity and endothelial dysfunction]. G Ital Cardiol (Rome) (2006) 0.81
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Am J Hypertens (2004) 0.81
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. Hypertens Res (2008) 0.81
Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens (2008) 0.81
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome. Endocrine (2014) 0.80
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension. J Hypertens (2001) 0.80
The role of the critical event committee in a major cardiovascular outcome study. Blood Press (2002) 0.80
Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects. Atherosclerosis (2005) 0.80
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. Nephrol Dial Transplant (2010) 0.80
Role of alcoholic beverages in essential hypertensive patients. Alcohol Alcohol (1995) 0.80